Trial Profile
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Dialysis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary) ; Calcitriol; Vitamin D; Vitamin D analogues
- Indications Secondary hyperparathyroidism
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 15 Sep 2014 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 04 Jun 2014 New trial record
- 09 Jul 2013